Company Filing History:
Years Active: 2008
Title: John S. Morris: Innovator in Cytomegalovirus Vaccines
Introduction
John S. Morris is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of vaccine development, particularly focusing on cytomegalovirus (CMV) vaccines. His innovative work has the potential to impact public health positively.
Latest Patents
John S. Morris holds a patent for an invention titled "Alpha virus-based cytomegalovirus vaccines." This patent provides methods and compositions that include a population of alphavirus replicon particles. These particles comprise alphavirus replicon RNAs, with one replicon RNA encoding cytomegalovirus pp65 and IE1 protein or immunogenic fragments thereof, while the second replicon RNA encodes cytomegalovirus gB protein or an immunogenic fragment thereof. Each of the two replicon RNAs is contained within a separate alphavirus replicon particle.
Career Highlights
Morris is associated with Alphavax, Incorporated, where he continues to advance his research and development efforts. His work in the field of vaccine technology showcases his commitment to addressing infectious diseases through innovative solutions.
Collaborations
Some of his notable coworkers include Jeffrey D. Chulay and Sergey A. Dryga. Their collaborative efforts contribute to the ongoing research and development in the field of virology and vaccine innovation.
Conclusion
John S. Morris is a prominent figure in the development of cytomegalovirus vaccines, with a patent that highlights his innovative approach to vaccine technology. His work at Alphavax, Incorporated, along with his collaborations, underscores his dedication to improving public health through scientific advancements.